Engineered probiotic boosts cancer therapy

Authors

DOI:

https://doi.org/10.25250/thescbr.brk695

Keywords:

cancer, cancer immunotherapy, probiotic, bacteria, immunology

Abstract

Nowadays, one of the main treatments for cancer is cancer immunotherapy. This therapy boosts a patient's immune system to fight cancer. A recent study attempts to help more patients benefit from this therapy, by engineering a probiotic to boost the effect of cancer immunotherapy.

Author Biography

Yonika Larasati, University of Geneva

PhD Student

Original article reference

Zhu, J., Ke, Y., Liu, Q., Yang, J., Liu, F., Xu, R., Zhou, H., Chen, A., Xiao, J., Meng, F., Yu, L., Li, R., Wei, J., & Liu, B. (2022). Engineered Lactococcus lactis secreting Flt3L and OX40 ligand for in situ vaccination-based cancer immunotherapy. Nature Communications, 13(1). https://doi.org/10.1038/s41467-022-35130-7

Downloads

  • URL

Published

2023-04-19

Issue

Vol. 9 No. 2 (2023): TheScienceBreaker

Section

Health & Physiology

License

Some rights reserved 2023 Yonika Larasati

Creative Commons License

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.